These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

669 related articles for article (PubMed ID: 16878323)

  • 41. Radiation safety aspects of brachytherapy for prostate cancer using permanently implanted sources. A report of ICRP Publication 98.
    International Commission on Radiological Protection
    Ann ICRP; 2005; 35(3):iii-vi, 3-50. PubMed ID: 16330284
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Second neoplasms after megavoltage radiation for pediatric tumors.
    Gold DG; Neglia JP; Dusenbery KE
    Cancer; 2003 May; 97(10):2588-96. PubMed ID: 12733158
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Health outcomes in older men with localized prostate cancer: results from the Prostate Cancer Outcomes Study.
    Hoffman RM; Barry MJ; Stanford JL; Hamilton AS; Hunt WC; Collins MM
    Am J Med; 2006 May; 119(5):418-25. PubMed ID: 16651054
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Risk of new primary nonbreast cancers after breast cancer treatment: a Dutch population-based study.
    Schaapveld M; Visser O; Louwman MJ; de Vries EG; Willemse PH; Otter R; van der Graaf WT; Coebergh JW; van Leeuwen FE
    J Clin Oncol; 2008 Mar; 26(8):1239-46. PubMed ID: 18323547
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Risk of second primary cancer following prostate cancer radiotherapy: DVH analysis using the competitive risk model.
    Takam R; Bezak E; Yeoh EE
    Phys Med Biol; 2009 Feb; 54(3):611-25. PubMed ID: 19124952
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Risk of second malignancies in survivors of retinoblastoma: more than 40 years of follow-up.
    Marees T; Moll AC; Imhof SM; de Boer MR; Ringens PJ; van Leeuwen FE
    J Natl Cancer Inst; 2008 Dec; 100(24):1771-9. PubMed ID: 19066271
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The impact of brachytherapy on prostate cancer-specific mortality for definitive radiation therapy of high-grade prostate cancer: a population-based analysis.
    Shen X; Keith SW; Mishra MV; Dicker AP; Showalter TN
    Int J Radiat Oncol Biol Phys; 2012 Jul; 83(4):1154-9. PubMed ID: 22270175
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Salivary gland cancer in the United States.
    Sun EC; Curtis R; Melbye M; Goedert JJ
    Cancer Epidemiol Biomarkers Prev; 1999 Dec; 8(12):1095-100. PubMed ID: 10613342
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Impact of brachytherapy on regional, racial, marital status, and age-related patterns of definitive treatment for clinically localized prostate carcinoma.
    Copeland LA; Elshaikh MA; Jackson J; Penner LA; Underwood W
    Cancer; 2005 Oct; 104(7):1372-80. PubMed ID: 16118801
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Patient and treatment factors associated with complications after prostate brachytherapy.
    Chen AB; D'Amico AV; Neville BA; Earle CC
    J Clin Oncol; 2006 Nov; 24(33):5298-304. PubMed ID: 17114664
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Risk of second malignancies after prostate irradiation?
    Müller AC; Ganswindt U; Bamberg M; Belka C
    Strahlenther Onkol; 2007 Nov; 183(11):605-9. PubMed ID: 17960335
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Pelvic radiotherapy and the risk of secondary leukemia and multiple myeloma.
    Wright JD; St Clair CM; Deutsch I; Burke WM; Gorrochurn P; Sun X; Herzog TJ
    Cancer; 2010 May; 116(10):2486-92. PubMed ID: 20209618
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Identifying men diagnosed with clinically localized prostate cancer who are at high risk for death from prostate cancer.
    D'Amico AV; Hui-Chen M; Renshaw AA; Sussman B; Roehl KA; Catalona WJ
    J Urol; 2006 Dec; 176(6 Pt 2):S11-5. PubMed ID: 17084157
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Late gastrointestinal toxicity after radiation for prostate cancer.
    Giordano SH; Lee A; Kuo YF; Freeman J; Goodwin JS
    Cancer; 2006 Jul; 107(2):423-32. PubMed ID: 16779795
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Perineural invasion affects biochemical recurrence-free survival in patients with prostate cancer treated with definitive external beam radiotherapy.
    Yu HH; Song DY; Tsai YY; Thompson T; Frassica DA; DeWeese TL
    Urology; 2007 Jul; 70(1):111-6. PubMed ID: 17656219
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cancer incidence rates among Lawrence Livermore National Laboratory (LLNL) employees: 1974-1997.
    Whorton MD; Moore DN; Seward JP; Noonan KA; Mendelsohn ML
    Am J Ind Med; 2004 Jan; 45(1):24-33. PubMed ID: 14691966
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Short- vs long-term androgen suppression plus external beam radiation therapy and survival in men of advanced age with node-negative high-risk adenocarcinoma of the prostate.
    D'Amico AV; Denham JW; Bolla M; Collette L; Lamb DS; Tai KH; Steigler A; Chen MH
    Cancer; 2007 May; 109(10):2004-10. PubMed ID: 17397033
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Rectourethral fistula after combination radiotherapy for prostate cancer.
    Marguet C; Raj GV; Brashears JH; Anscher MS; Ludwig K; Mouraviev V; Robertson CN; Polascik TJ
    Urology; 2007 May; 69(5):898-901. PubMed ID: 17482930
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Bidirectional association of anogenital and oral cavity/pharyngeal carcinomas in men.
    Sikora AG; Morris LG; Sturgis EM
    Arch Otolaryngol Head Neck Surg; 2009 Apr; 135(4):402-5. PubMed ID: 19380365
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Improved survival with adjuvant external-beam radiation therapy in lymph node-negative pancreatic cancer: a United States population-based assessment.
    Artinyan A; Hellan M; Mojica-Manosa P; Chen YJ; Pezner R; Ellenhorn JD; Kim J
    Cancer; 2008 Jan; 112(1):34-42. PubMed ID: 18000805
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 34.